الولايات المتحدة · منصات وبيانات · MarketBeat

What Travere Therapeutics (TVTX) Said on Its Q3 Earnings Call

نشره MarketBeat · الولايات المتحدة منذ 2 س

Travere Therapeutics (NASDAQ:TVTX) reported third-quarter results marked by record FILSPARI sales, continued early adoption in focal segmental glomerulosclerosis (FSGS), and…

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

Seeking Alpha

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

The Motley Fool

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

MarketWatch

Apple’s iPhone business is booming. Here’s why the stock is falling anyway.

Investing.com

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

CNBC

Stock market after midterm elections: What S&P 500 history shows

TipRanks